PubMed Health⌕ Search

PubMed · 3064670

[Cervical lymph node inflammation in children].

Abstract

One hundred and twenty seven cases of cervical lymph node infection were seen between 1974 and 1986 in children aged between 1 month and 10 years. The point of origin of the infection wa identified in 30% of cases and was, in decreasing order: cutaneous, in the cervico-cephalic region; pharyngo-tonsillar via the lymphatic structures of the pharynx or by direct effraction of the buccopharyngeal mucosa; and, finally, dental. The site of the secondary lymph node infection was generally below and behind the angle of the jaw and in some cases submandibular. Two thirds of cases progressed to suppuration and were evaluated bacteriologically. Four organisms were identified: Staphylococcus, very much in the majority. The origin of the infection was almost always cutaneous. There was a predilection for the child aged under 5 with a majority under 2. The streptococcus was in second place far behind the staphylococcus. The origin of the infection was pharyngo-tonsillar, with the beta-haemolytic streptococcus predominant, bucco-dental, with the alpha-haemolytic predominant, and a very small number of cases with a cutaneous origin. The age of these children was greater than in the staphylococcal infection group: the great majority were over 2 and all cases with a dental origin were aged over 5. There were a small number of anaerobic infections. In 2 of the 3 bacteriologically confirmed cases, the origin was pharyngo-tonsillar and development was obviously favored by the initial antibiotics prescribed. Management took into account the predominance of the staphylococcus, the resistance of this organism to penicillin G and its usual sensitivity to methicillin.(ABSTRACT TRUNCATED AT 250 WORDS)

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

F Pain, B Plainfosse. 1988. [Cervical lymph node inflammation in children].. https://pubmed.ncbi.nlm.nih.gov/3064670/

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

Persistent bacterial infections and primary immune disorders.

Mycobacteria, Salmonella and Helicobacter species have all evolved mechanisms to evade host defenses and cause persistent infection in humans. Host control of mycobacteria and Salmonella is largely achieved by the IFN-gamma/IL-12 pathway. Immune disorders affecting this pathway are characterized by disseminated infections with environmental or nontuberculous mycobacteria. Helicobacter is a predominantly extracellular bacterium that uses its remarkable genetic diversity (as well as other mechanisms) in order to evade host defenses. The importance of humoral immunity in containing Helicobacter infections to the mucosal surface is illustrated by the primary immune disorder, X-linked agammaglobulinemia in which patients are prone to chronic bacteremia and skin infections by Helicobacter and related species such as Flexispira and Campylobacter. Exploration of these particular infections in their specific immune defects sheds light on both host and bacterial mechanisms that have implications for pathogenesis and therapy.

Bacterial Infections↗

The importance of vaccination.

We have vaccines for nearly thirty of the more than seventy infectious diseases which are pathogenic for humans. Most of the vaccines, especially those to prevent childhood diseases, are highly effective with a high safety profile. Vaccines are being developed against many of the other bacteria and viruses, and some parasites. Occasionally, a new vaccine has to be withdrawn because of unexpected side effects. Smallpox remains the only infectious disease to have been eradicated. The Global Program to eradicate poliomyelitis initiated in 1988, has unfortunately run into difficulties. A few children immunised with the Sabin oral vaccine fail to clear the virus which can mutate over some years into a pathogenic form and spread rapidly unless large vaccination programs are re-introduced. Of major concern are emerging and re-emerging infectious diseases, especially HIV, for which there is currently no vaccine. Fortunately, new techniques are becoming available making it possible to consider developing vaccines based on inducing strong cell-mediated immune responses to control the agent's replication when antigenic variation in surface antigens (e.g. HIV, influenza) makes classical techniques based on induction of antibody responses less attractive.

Bacterial Infections↗